MELIORA Data Collection Campaigns

Recruiting now · Not applicable

Conditions studied: Breast Cancer Prevention

In brief

To support the development of the MELIORA digital app for the MELIORA main intervention, an initial pilot study (Data Collection Campaign, DCC) is being conducted with the three target participant groups: healthy women at increased risk of developing breast cancer (BC), BC patients, and BC survivors across the four intervention countries (Spain, Greece, Lithuania, Sweden). The planned sample size for each group is 156 healthy women at risk (defined as not meeting recommendations for a healthy lifestyle), 58 BC patients, and 86 BC survivors. Each participant is asked to test and evaluate a preliminary version of the MELIORA app over a 14-day period. The DCC takes place in the early stages of the project, as part of the intervention development phase, to inform the technical refinement and preliminary evaluation of the MELIORA digital app.

Key facts

Study ID: NCT07190066
Run by: Harokopio University
People needed: 300
Starts: 2025-04-22
Expected to finish: 2025-09-30
Last updated by the study team: 2025-09-30

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

Individuals residing in Greece, Lithuania, Spain or Sweden.
Female adults (i.e. ≥18 years of age).
Ability to understand and complete the outcome measures in one of the participating countries' local languages.
Ability to provide fully informed consent.
Having access to and being able to use a smartphone that supports the project app (i.e., iOS or Android smartphone)
Meeting the criteria for allocation to one of the three following groups:
Healthy women with a calculated Βody Μass Ιndex (BMI) ≥ 25 or not meeting the World Health Organization's recommendations of ≥150 minutes of moderate-to-vigorous physical activity per week.
Women currently undergoing active treatment for breast cancer or awaiting to begin active treatment for breast cancer.
Women survivors of BC having completed active treatment at least six months prior to study enrolment

You may not qualify if…

Inability to provide fully informed consent.
Inability to understand and communicate in one of the recruitment countries' local languages.

Where it is running

Harokopio University — Athens, Greece (enrolling)
Lietuvos Sveikatos Mokslų Universitetas (Lsmu) — Kaunas, Lithuania (enrolling)
Pagalbos Onkologiniams Ligoniams Asociacija (Pola L T) — Kaunas, Lithuania (enrolling)
Fundación Para El Fomento de La Investigación Sanitaria Y Biomédica de La Comunitat Valenciana (Fisabio) — Valencia, Spain (enrolling)
INCLIVA - Instituto de Investigación Sanitaria — Valencia, Spain (enrolling)
Bröstcancerföreningen Amazona I Stockholms Län (Amazona) — Stockholm, Sweden (enrolling)
Karolinska Institutet — Stockholm, Sweden (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.